Skip to main content
. 2021 May 21;18:97–101. doi: 10.1016/j.reth.2021.04.003

Fig. 2.

Fig. 2

Efficacy endpoints assessment during the trial observation period. Serum albumin concentration (A) and prothrombin activity (B) of each enrolled patient.